Mosaic Therapeutics

Mosaic Biomedicals

This drug discovery company develops personalised cancer treatments targeting stem cells and the immune system for patients with solid tumours.

Mnemo Therapeutics

This biotechnology company develops cell therapies and an epigenetic antigen discovery platform to treat solid tumours and blood cancers for healthcare providers.

Mersana Therapeutics

This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.

Momentous Therapeutics

This company develops pan-cancer drugs and therapeutic treatments for the pharmaceutical industry to address challenging biological targets.

MyCural Therapeutics

This company develops small molecule drugs targeting the MYC oncoprotein to treat patients with aggressive, high-risk cancers.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

MPC Therapeutics

This biotechnology company develops mitochondrial pyruvate carrier targeted therapies and small molecule supplements to enhance cellular immunotherapies for cancer patients and healthcare providers.

Enedra Therapeutics Ltd

This company develops precision medicines and biomarkers to treat advanced, genetically heterogeneous cancers for patients with drug-resistant tumours.